Cheezheng Pain Relief Cream

Description

Cheezheng Pain Relief Cream is formulated as a topical cream available in two sizes: 20 grams and 55 grams. The product is packaged in both bilingual and English versions for the inner and outer boxes, ensuring accessibility for a diverse user base. Accompanying the product are images of the packaging, which include the 20g and 55g bilingual and English outer and inner boxes.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as arthritis, strains, simple backache, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, the recommended application is to apply the product generously to the affected area. The product should be massaged into the painful area until it is thoroughly absorbed into the skin. Applications should not exceed 3 to 4 times daily.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Application is contraindicated in the following situations:

• Do not apply to irritated skin, wounds, or damaged skin, or if excessive irritation develops, due to the potential for exacerbating the condition.

• Use is contraindicated within 1 hour prior to bathing or within 30 minutes after bathing, as this may affect the product's efficacy.

• Avoid tight bandaging or the use of heating pads in conjunction with the product, as this may increase the risk of adverse effects.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid contact with eyes and mucous membranes. The product should be used strictly as directed to ensure safety and efficacy.

It is imperative to avoid bandaging the area tightly or using a heating pad in conjunction with the product. Patients should refrain from applying the product one hour prior to bathing and within 30 minutes after bathing. Application to irritated skin, wounds, or damaged skin is contraindicated. If excessive irritation develops, the use of the product should be discontinued immediately.

In the event of accidental ingestion, it is crucial to keep the product out of reach of children. Patients should be instructed to seek emergency medical assistance or contact a Poison Control Center without delay.

Patients should be advised to stop using the product and consult their healthcare provider if any of the following occur: worsening of the condition, excessive skin irritation, presence of redness, or if symptoms or pains persist for more than seven days or resolve and then recur within a few days.

Side Effects

For external use only. Patients are advised to stop use and consult a doctor if any of the following occur: the condition worsens, excessive skin irritation develops, redness is present, or symptoms or pains persist for more than 7 days or resolve and then recur within a few days.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cheezheng Pain Relief Cream (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and adults aged 12 years and older, the product should be applied generously to the affected area.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and therefore, caution is advised.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this drug in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment may require dosage adjustments due to reduced renal function. It is essential to monitor renal function tests regularly in individuals with known kidney problems. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose should be considered to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, it is essential to seek immediate medical attention. Healthcare providers should assess the patient's clinical status and consider the need for supportive care. Monitoring vital signs and providing symptomatic treatment may be necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise. Symptoms can vary widely depending on the medication involved and the individual patient's response.

Management Procedures Management of overdosage should be tailored to the specific circumstances, including the amount ingested and the time since ingestion. Activated charcoal may be considered if the patient presents within a suitable timeframe and is alert. In cases of severe toxicity, advanced medical interventions may be required.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on managing overdosage cases effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has revealed reports of skin irritation and allergic reactions associated with the use of Cheezheng Pain Relief Cream. These events were reported voluntarily or identified through surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the medication within 1 hour prior to bathing or within 30 minutes after bathing to ensure optimal effectiveness. It is important to emphasize that the medication should not be applied to irritated skin, wounds, or damaged skin. Patients should be cautioned to discontinue use if excessive irritation develops.

Healthcare providers should remind patients to avoid contact with the eyes and mucous membranes, and to use the medication only as directed. Patients should be advised against tightly bandaging the area where the medication is applied or using it in conjunction with a heating pad.

Patients should be instructed to monitor their condition closely. They should report to their healthcare provider if their condition worsens, if excessive skin irritation occurs, if redness is present, or if symptoms or pains persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct sunlight and moisture. To maintain safety, it is essential to keep the product out of reach of children. Once opened, the product must be discarded to ensure proper handling and safety.

Additional Clinical Information

Patients should apply the medication generously to the affected area, massaging it into the skin until fully absorbed. For adults and children over 12 years, the application should not exceed 3 to 4 times daily. For children under 12 years, it is advised to consult a doctor before use.

Clinicians should counsel patients to seek medical advice if they are pregnant or breastfeeding. Patients should avoid contact with eyes and mucous membranes, use the product only as directed, and refrain from tightly bandaging the area or using it with a heating pad. Additionally, the medication should not be applied within one hour prior to bathing or within 30 minutes after bathing, and it should not be used on irritated, wounded, or damaged skin, especially if excessive irritation occurs.

Drug Information (PDF)

This file contains official product information for Cheezheng Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)